MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line

IntroductionDemyelination is one of the hallmarks of multiple sclerosis (MS). While remyelination occurs during the disease, it is incomplete from the start and strongly decreases with its progression, mainly due to the harm to oligodendrocyte progenitor cells (OPCs), causing irreversible neurologic...

Full description

Bibliographic Details
Main Authors: Océane Perdaens, Pauline Bottemanne, Vincent van Pesch
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fncel.2024.1336439/full
_version_ 1797291893445361664
author Océane Perdaens
Pauline Bottemanne
Vincent van Pesch
Vincent van Pesch
author_facet Océane Perdaens
Pauline Bottemanne
Vincent van Pesch
Vincent van Pesch
author_sort Océane Perdaens
collection DOAJ
description IntroductionDemyelination is one of the hallmarks of multiple sclerosis (MS). While remyelination occurs during the disease, it is incomplete from the start and strongly decreases with its progression, mainly due to the harm to oligodendrocyte progenitor cells (OPCs), causing irreversible neurological deficits and contributing to neurodegeneration. Therapeutic strategies promoting remyelination are still very preliminary and lacking within the current treatment panel for MS.MethodsIn a previous study, we identified 21 microRNAs dysregulated mostly in the CSF of relapsing and/or remitting MS patients. In this study we transfected the mimics/inhibitors of several of these microRNAs separately in an OPC cell line, called CG-4. We aimed (1) to phenotypically characterize their effect on OPC differentiation and (2) to identify corroborating potential mRNA targets via immunocytochemistry, RT-qPCR analysis, RNA sequencing, and Gene Ontology enrichment analysis.ResultsWe observed that the majority of 13 transfected microRNA mimics decreased the differentiation of CG-4 cells. We demonstrate, by RNA sequencing and independent RT-qPCR analyses, that miR-33-3p, miR-34c-5p, and miR-124-5p arrest OPC differentiation at a late progenitor stage and miR-145-5p at a premyelinating stage as evidenced by the downregulation of premyelinating oligodendrocyte (OL) [Tcf7l2, Cnp (except for miR-145-5p)] and mature OL (Plp1, Mbp, and Mobp) markers, whereas only miR-214-3p promotes OPC differentiation. We further propose a comprehensive exploration of their change in cell fate through Gene Ontology enrichment analysis. We finally confirm by RT-qPCR analyses the downregulation of several predicted mRNA targets for each microRNA that possibly support their effect on OPC differentiation by very distinctive mechanisms, of which some are still unexplored in OPC/OL physiology.ConclusionmiR-33-3p, miR-34c-5p, and miR-124-5p arrest OPC differentiation at a late progenitor stage and miR-145-5p at a premyelinating stage, whereas miR-214-3p promotes the differentiation of CG-4 cells. We propose several potential mRNA targets and hypothetical mechanisms by which each microRNA exerts its effect. We hereby open new perspectives in the research on OPC differentiation and the pathophysiology of demyelination/remyelination, and possibly even in the search for new remyelinating therapeutic strategies in the scope of MS.
first_indexed 2024-03-07T19:44:22Z
format Article
id doaj.art-53ec7d09a17a4d18a5df94f7c2add396
institution Directory Open Access Journal
issn 1662-5102
language English
last_indexed 2024-03-07T19:44:22Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular Neuroscience
spelling doaj.art-53ec7d09a17a4d18a5df94f7c2add3962024-02-29T04:33:36ZengFrontiers Media S.A.Frontiers in Cellular Neuroscience1662-51022024-02-011810.3389/fncel.2024.13364391336439MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell lineOcéane Perdaens0Pauline Bottemanne1Vincent van Pesch2Vincent van Pesch3Neurochemistry Group, Institute of NeuroScience, Université catholique de Louvain (UCLouvain), Brussels, BelgiumBioanalysis and Pharmacology of Bioactive Lipids, Louvain Drug Research Institute, Université catholique de Louvain (UCLouvain), Brussels, BelgiumNeurochemistry Group, Institute of NeuroScience, Université catholique de Louvain (UCLouvain), Brussels, BelgiumDepartment of Neurology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, BelgiumIntroductionDemyelination is one of the hallmarks of multiple sclerosis (MS). While remyelination occurs during the disease, it is incomplete from the start and strongly decreases with its progression, mainly due to the harm to oligodendrocyte progenitor cells (OPCs), causing irreversible neurological deficits and contributing to neurodegeneration. Therapeutic strategies promoting remyelination are still very preliminary and lacking within the current treatment panel for MS.MethodsIn a previous study, we identified 21 microRNAs dysregulated mostly in the CSF of relapsing and/or remitting MS patients. In this study we transfected the mimics/inhibitors of several of these microRNAs separately in an OPC cell line, called CG-4. We aimed (1) to phenotypically characterize their effect on OPC differentiation and (2) to identify corroborating potential mRNA targets via immunocytochemistry, RT-qPCR analysis, RNA sequencing, and Gene Ontology enrichment analysis.ResultsWe observed that the majority of 13 transfected microRNA mimics decreased the differentiation of CG-4 cells. We demonstrate, by RNA sequencing and independent RT-qPCR analyses, that miR-33-3p, miR-34c-5p, and miR-124-5p arrest OPC differentiation at a late progenitor stage and miR-145-5p at a premyelinating stage as evidenced by the downregulation of premyelinating oligodendrocyte (OL) [Tcf7l2, Cnp (except for miR-145-5p)] and mature OL (Plp1, Mbp, and Mobp) markers, whereas only miR-214-3p promotes OPC differentiation. We further propose a comprehensive exploration of their change in cell fate through Gene Ontology enrichment analysis. We finally confirm by RT-qPCR analyses the downregulation of several predicted mRNA targets for each microRNA that possibly support their effect on OPC differentiation by very distinctive mechanisms, of which some are still unexplored in OPC/OL physiology.ConclusionmiR-33-3p, miR-34c-5p, and miR-124-5p arrest OPC differentiation at a late progenitor stage and miR-145-5p at a premyelinating stage, whereas miR-214-3p promotes the differentiation of CG-4 cells. We propose several potential mRNA targets and hypothetical mechanisms by which each microRNA exerts its effect. We hereby open new perspectives in the research on OPC differentiation and the pathophysiology of demyelination/remyelination, and possibly even in the search for new remyelinating therapeutic strategies in the scope of MS.https://www.frontiersin.org/articles/10.3389/fncel.2024.1336439/fullmultiple sclerosismicroRNAmiR-33-3pmiR-34c-5pmiR-124-5pmiR-214-3p
spellingShingle Océane Perdaens
Pauline Bottemanne
Vincent van Pesch
Vincent van Pesch
MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line
Frontiers in Cellular Neuroscience
multiple sclerosis
microRNA
miR-33-3p
miR-34c-5p
miR-124-5p
miR-214-3p
title MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line
title_full MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line
title_fullStr MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line
title_full_unstemmed MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line
title_short MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line
title_sort micrornas dysregulated in multiple sclerosis affect the differentiation of cg 4 cells an oligodendrocyte progenitor cell line
topic multiple sclerosis
microRNA
miR-33-3p
miR-34c-5p
miR-124-5p
miR-214-3p
url https://www.frontiersin.org/articles/10.3389/fncel.2024.1336439/full
work_keys_str_mv AT oceaneperdaens micrornasdysregulatedinmultiplesclerosisaffectthedifferentiationofcg4cellsanoligodendrocyteprogenitorcellline
AT paulinebottemanne micrornasdysregulatedinmultiplesclerosisaffectthedifferentiationofcg4cellsanoligodendrocyteprogenitorcellline
AT vincentvanpesch micrornasdysregulatedinmultiplesclerosisaffectthedifferentiationofcg4cellsanoligodendrocyteprogenitorcellline
AT vincentvanpesch micrornasdysregulatedinmultiplesclerosisaffectthedifferentiationofcg4cellsanoligodendrocyteprogenitorcellline